2.5 mg of semaglutide Ozempic 2 mg/1.5 mL (1.34 mg/mL) prefilled pen that delivers 0.25 or 0.5 mg per injection Images Semaglutide Flex-Dose 2 mL Injectable
Description
The First Phase Key details and approval criteria for liraglutide (Saxenda) for weight management include a target patient age of 18 years and older with a body mass index (BMI) of 30 kg/m2 or greater, or a BMI of 27 kg/m2 or greater with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia

The TRIUMPH-4 Phase 3 readout in April 2026 extended that to 28.7% at 68 weeks in a population with knee osteoarthritis - a patient group in whom weight loss produces disproportionate benefit on a secondary outcome (pain) the trial measured and reported as a 75.8% reduction on the WOMAC pain index

Our team ensures every Columbus resident can access effective weight loss treatments, accommodating uninsured patients by discussing all conceivable options

Gently expand food variety As tolerance improves, some people begin adding more textures and flavors

Drinking plenty of water and electrolytes can help manage this

These medications have also demonstrated positive effects on fatty liver disease, enhancing their appeal in managing obesity-related conditions
